Lawrence Gelber, MD
Allergy · Richmond, VANPI 1003865726
Payments from drug & device makers
Across 716 payments — averaging $2621.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kaleo, Inc.$1.9M
- AstraZeneca$2K
- Regeneron Healthcare Solutions, Inc.$2K
- Sanofi$1K
- Genentech USA, Inc.$1K
- GSK$874
- plus $6K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kaleo, Inc. | 49 | $1,863,830 |
| AstraZeneca | 82 | $2,246 |
| Regeneron Healthcare Solutions, Inc. | 65 | $1,506 |
| Sanofi | 58 | $1,410 |
| Genentech USA, Inc. | 61 | $1,127 |
| GSK | 75 | $874 |
| Amgen | 36 | $779 |
| Optinose US, Inc. | 41 | $710 |
| Novartis | 36 | $690 |
| CSL Behring | 37 | $679 |
| Grifols USA, LLC | 27 | $484 |
| Biocryst US Sales Co., LLC | 15 | $313 |
| Pfizer | 19 | $290 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $287 |
| Teva Pharmaceuticals USA, Inc. | 13 | $264 |
| Blueprint Medicines Corporation | 9 | $255 |
| ARS Pharmaceuticals Operations, Inc. | 16 | $252 |
| Sanofi-aventis U.S. LLC | 3 | $196 |
| Boehringer Ingelheim | 12 | $184 |
| Pharming Healthcare, Inc. | 11 | $168 |
| Incyte Corporation | 5 | $125 |
| Aimmune Therapeutics, Inc. | 6 | $103 |
| Alk-abello, Inc | 4 | $71 |
| Dermavant Sciences, Inc. | 1 | $68 |
| Greer Laboratories, Inc. | 3 | $60 |
| Covis Pharma GmbH | 3 | $57 |
| Azurity Pharmaceuticals, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $40 |
| Phadia US Inc. | 2 | $35 |
| Hikma Pharmaceuticals USA | 2 | $35 |
| AbbVie | 2 | $31 |
| Organon | 1 | $25 |
| Ionis Pharmaceuticals, Inc. | 1 | $24 |
| Eyevance Pharmaceuticals LLC | 1 | $23 |
| Merck | 1 | $14 |
| Biocryst Pharmaceuticals, Inc. | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $12 |
How this compares
$1,877,321 in reported general payments places this provider in the 95th percentile of 26 allergy providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in Richmond
- Robert CallRichmond$35.8M
- William HarkRichmond$945K
- Muhammad RaisRichmond$31K
- Zeeshan KhakwaniRichmond$8K
- Kimberly GeorgeRichmond$2K
- Thomas Platts MillsCharlottesville$176K
- Kelly MaplesNorfolk$26K
- Jaimin PatelHenrico$14K
- Sarah SprietFort Belvoir$9K
- Laura IspasLeesburg$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.